Skip to content

13F-HR filed by Yu Fan

Yu Fan filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-14, with 4 holding rows worth $19,953,589.

Accession
0000950123-24-002149
Filed
2024-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2023

A combination report, 4 entries on the cover page, a total value of $19,953,589 stated on the cover page (in dollars after the unit check, H1), rows summing to $19,953,589 with VALUE read as dollars as filed, 13F file number 028-20833. The quarter's positions are built on this report. The resolved quarter.

Other managers

  • reports for this filerABG Innovation Capital Partners III GP Limited 028-20837
  • reports for this filerAlly Bridge Group (NY) LLC 028-20834

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CARGO THERAPEUTICS INC COM14179K101Stock822,171$19,033,259dollars as filed
CASTLE BIOSCIENCES INC14843C105COMMON STOCK22,503$485,615dollars as filed
SAGIMET BIOSCIENCES INC A786700104COMMON STOCK57,190$309,970dollars as filed
PYXIS ONCOLOGY INC COMMON STOCK747324101Stock69,303$124,745dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-24-002149this filing2024-02-14acceptance time not in the bulk data set